What is this webinar about?
There is tremendous regulatory support for utilizing risk in managing clinical trials. Risk-based monitoring has been growing in popularity over the past 15 years and this year's Covid-19 pandemic on clinical trials has only driven this growth further.
With the increasing power of artificial intelligence and machine learning in TMF management, applying risk strategies in TMF oversight is becoming a means of gaining efficiencies without impacting quality. This session examines the applications of AI and machine learning in planning and conducting TMF oversight activities. We also discuss how these technologies will empower remote site access and clinical trial collaboration.